Supporting Decision Making for Musculoskeletal Preference-Sensitive Care
Launched by HEALTH DIALOG · Apr 28, 2011
Trial Information
Current as of June 12, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Participants in two large, commercial Blue Cross and/or Blue Shield branded insurance products with eligibility for Health Dialog services
- • Identified by distinct Health Dialog proprietary models for risk of lumbar back, knee or hip surgeries
- • Selected by simple randomization for inclusion in an interactive voice response (IVR) administered screening survey
- • Participated in an IVR-administered screener survey and responded affirmatively to questions on pain for any one of the three conditions, any current or planned treatment for the conditions, and responded negatively to having had a condition specific surgery within the past six months
- Exclusion Criteria:
- • People under 18 years of age at time of identification for the IVR filtering survey, approximately 6 weeks prior to the start of the study
- • People with invalid phone numbers or invalid mailing addresses based on automated review of those fields
- • People for whom Health Dialog has information of a request for no IVR, no Health Coach outreach, or mailings prior to the start of the study
- • People with claims based indication of spinal stenosis prior to the start of the study
- • People who have been targeted for any IVR outreach within 180 days of the initiation of the IVR filtering survey
- • People who have a Health Coach communication record, as documented in the Health Coaching application within 90 days of the start of the study
- • Any members of households who have a household member already selected for inclusion in the study
- • People for whom there is claims evidence of any one of the targeted surgeries prior the start of the study
- • People with no eligibility for services through insurer after the start of the study
About Health Dialog
Health Dialog is a leading healthcare organization that specializes in providing innovative solutions to improve patient outcomes and enhance healthcare decision-making. With a focus on personalized health management, Health Dialog employs a data-driven approach, leveraging advanced analytics and evidence-based practices to deliver tailored interventions for individuals with chronic conditions. The organization collaborates with healthcare providers, payers, and patients to facilitate effective care coordination and optimize health resources. Through its commitment to patient engagement and empowerment, Health Dialog aims to transform the healthcare landscape by fostering informed health choices and promoting sustainable wellness.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Boston, Massachusetts, United States
Patients applied
Trial Officials
David R Veroff, MPP
Principal Investigator
Health Dialog Services Corporation
Patricia M Gallagher, PHD
Study Director
University of Massachusetts, Boston
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials